ADAP - Adaptimmune Therapeutics PLC (ADAP) CEO Adrian Rawcliffe on Q4 2019 Results - Earnings Call Transcript
Adaptimmune Therapeutics PLC (ADAP)
Q4 2019 Earnings Conference Call
November 06, 2019, 08:00 ET
Company Participants
Juli Miller - Director, IR
Adrian Rawcliffe - CEO, Principal Accounting Officer & Director
Elliot Norry - Acting Chief Medical Officer
John Lunger - Chief Patient Supply Officer
Michael Garone - Interim CFO
Conference Call Participants
Mohit Bansal - Citigroup
Marc Frahm - Cowen and Company
Tony Butler - Roth Capital Partners
Nicholas Abbott - Wells Fargo Securities
Michael Schmidt - Guggenheim Securities
Daniel Leather - Polygon
John Barrett - SVB Leerink
Presentation
Operator
Ladies and gentlemen, thank you